Total Payments
$7,478
2023 Payments
$59.59
Companies
24
Transactions
121
Medicare Patients
421
Medicare Billing
$52,615
Payment Breakdown by Category
Food & Beverage$5,208 (69.6%)
Research$1,550 (20.7%)
Consulting$650.00 (8.7%)
Education$70.54 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,208 | 113 | 69.6% |
| Unspecified | $1,550 | 3 | 20.7% |
| Consulting Fee | $650.00 | 2 | 8.7% |
| Education | $70.54 | 3 | 0.9% |
Payments by Type
General
$5,928
118 transactions
Research
$1,550
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim b.v. | $1,550 | 3 | $0 (2017) |
| Novo Nordisk Inc | $1,256 | 25 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $682.04 | 17 | $0 (2022) |
| Amgen Inc. | $622.63 | 7 | $0 (2019) |
| Promius Pharma LLC | $603.85 | 2 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $525.16 | 12 | $0 (2020) |
| PFIZER INC. | $446.50 | 12 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $348.76 | 14 | $0 (2021) |
| AbbVie Inc. | $300.42 | 5 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $249.27 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $59.59 | 1 | Novo Nordisk Inc ($59.59) |
| 2022 | $101.32 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($54.81) |
| 2021 | $647.70 | 20 | AbbVie Inc. ($219.78) |
| 2020 | $105.74 | 6 | Novo Nordisk Inc ($59.11) |
| 2019 | $1,383 | 31 | Novo Nordisk Inc ($480.35) |
| 2018 | $1,563 | 34 | PFIZER INC. ($327.08) |
| 2017 | $3,618 | 25 | Boehringer Ingelheim b.v. ($1,550) |
All Payment Transactions
121 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/17/2023 | Novo Nordisk Inc | Sogroya (Biological) | Food and Beverage | In-kind items and services | $59.59 | General |
| Category: Growth Hormone | ||||||
| 03/14/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $32.52 | General |
| Category: DIABETES | ||||||
| 02/09/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $30.34 | General |
| Category: Cardio-renal | ||||||
| 01/26/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Diabetes | ||||||
| 01/25/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: DIABETES | ||||||
| 10/27/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Diabetes | ||||||
| 09/20/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/15/2021 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/14/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: DIABETES | ||||||
| 08/25/2021 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/18/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Diabetes | ||||||
| 07/28/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $97.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/07/2021 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/06/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $31.00 | General |
| Category: DIABETES | ||||||
| 06/30/2021 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Endocrinology | ||||||
| 06/16/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/26/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $71.94 | General |
| Category: IMMUNOLOGY | ||||||
| 05/19/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Diabetes | ||||||
| 05/13/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $100.80 | General |
| Category: IMMUNOLOGY | ||||||
| 05/12/2021 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Endocrinology | ||||||
| 05/05/2021 | Lilly USA, LLC | LYUMJEV (Drug) | Food and Beverage | In-kind items and services | $29.17 | General |
| Category: Diabetes | ||||||
| 04/28/2021 | AbbVie Inc. | LINZESS (Drug), ANDROGEL | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/13/2021 | Ultragenyx Pharmaceutical Inc. | — | Food and Beverage | In-kind items and services | $21.39 | General |
| 03/24/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Diabetes | ||||||
| 03/16/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.77 | General |
| Category: DIABETES | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| safety and efficacy linagliptin vs SU | Boehringer Ingelheim b.v. | $1,550 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 11 | 12 | $1,128 | $376.00 |
| 2021 | 5 | 183 | 256 | $28,870 | $21,534 |
| 2020 | 5 | 227 | 394 | $42,805 | $30,705 |
Total Patients
421
Total Services
662
Medicare Billing
$52,615
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 12 | $1,128 | $376.00 | 33.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 65 | 105 | $9,870 | $6,974 | 70.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 42 | 42 | $7,275 | $6,002 | 82.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 52 | 85 | $6,970 | $4,604 | 66.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 11 | 11 | $2,090 | $1,985 | 95.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 13 | 13 | $2,665 | $1,970 | 73.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 67 | 67 | $12,456 | $11,507 | 92.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 74 | 149 | $14,006 | $8,836 | 63.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 59 | 114 | $9,348 | $5,365 | 57.4% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 12 | 49 | $3,920 | $2,731 | 69.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 15 | 15 | $3,075 | $2,267 | 73.7% |
About Dr. Stephen Smith, MD
Dr. Stephen Smith, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588732077.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Smith, MD has received a total of $7,478 in payments from pharmaceutical and medical device companies, with $59.59 received in 2023. These payments were reported across 121 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($5,208).
As a Medicare-enrolled provider, Smith has provided services to 421 Medicare beneficiaries, totaling 662 services with total Medicare billing of $52,615. Data is available for 3 years (2020–2022), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Baltimore, MD
- Active Since 12/01/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1588732077
Products in Payments
- TRADJENTA (Drug) $1,685
- Zembrace (Drug) $603.85
- Ozempic (Drug) $528.23
- JARDIANCE (Drug) $516.76
- XARELTO (Drug) $329.73
- Repatha (Biological) $315.32
- EUCRISA (Drug) $306.73
- Victoza (Drug) $302.89
- FARXIGA (Drug) $228.01
- Tresiba (Drug) $219.94
- STEGLATRO (Drug) $216.73
- Aimovig (Biological) $196.90
- INVOKANA (Drug) $195.43
- SYNTHROID (Drug) $172.74
- CHANTIX (Drug) $139.77
- Norditropin (Drug) $113.17
- Prolia (Biological) $110.41
- JANUVIA (Drug) $109.07
- SOLIQUA (Drug) $106.06
- HUMULIN (Drug) $101.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Baltimore
Adrian Dobs, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $199,807
Endocrinology, Diabetes & Metabolism $199,807
Dr. Asif Mohamed, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $101,877
Endocrinology, Diabetes & Metabolism $101,877
Jean Park, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $69,400
Endocrinology, Diabetes & Metabolism $69,400
Roberto Salvatori, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $68,240
Endocrinology, Diabetes & Metabolism $68,240
Dr. Nowreen Haq, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $54,628
Endocrinology, Diabetes & Metabolism $54,628
Sherita Golden, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $12,746
Endocrinology, Diabetes & Metabolism $12,746